Schizophrenia: open trials in Czechia

• 2024-519836-18-00

  Evenamide in patients with treatment-resistant schizophrenia not responding to antipsychotics

  Trial Treatment · Phase 3 · Newron Pharmaceuticals S.p.A.

  Medipa S R O, Brno · Narodni Ustav Dusevniho Zdravi, Klecany · Psychiatrie-ambulance s.r.o., Plzen · A-Shine s.r.o., Plzen 3 · Clintrial s.r.o., Prague 10

  Registry updated 2026-11-04

• NCT06540833

  A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

  Trial Treatment · Phase 2 · Intra-Cellular Therapies, Inc.

  Fakultni nemocnice u sv. Anny v Brne, Brno · Neuro Health Centrum S.R.O, Brno · NEUROHK s r o, Hradec Králové · INEP medical s.r.o., Prague

  Registry updated 2026-11-03

• NCT07686263

  Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

  Trial Treatment · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company

  Brno · Klecany

  Registry updated 2026-10-30

• NCT06887192

  A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

  Trial Treatment · Phase 2 · MapLight Therapeutics

  Fakultni Nemocnice U Sv Anny V Brne, Brno-Stred · NEUROHK s r o, Choceň · Pratia Pardubice a.s., Pardubice I · Praglandia s.r.o., Prague

  Registry updated 2026-09-30

• NCT07459660

  An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis

  Trial Treatment · Phase 2 · MapLight Therapeutics

  Fakultni Nemocnice U Sv Anny V Brne, Brno-Stred · NEUROHK s r o, Choceň · Pratia Czech s.r.o., Pardubice I · Praglandia s.r.o., Prague

  Registry updated 2026-08-07

• NCT07397975

  Speech-based Assessment of Relapse Risk in People With Psychosis

  Research · Philipp Homan

  National Institute of Mental Health, Klecany

  Registry updated 2026-02-09

All Schizophrenia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error